SeaStar Medical Q3 Revenue Rises to $635,000 as Net Loss Widens to $4.5 Million

SeaStar Medical reported third-quarter 2026 revenue of $635,000, up from $183,000 a year earlier, while net loss increased to $4.5 million from $3.5 million. Gross profit was $587,000, and cash totaled $4.0 million at September 30. The company also reported progress in its adult AKI trial and new r…